Anxiety · GAD-7

How anxious are you really?

La scala GAD-7 (Disturbo d'Ansia Generalizzata, 7 item) è lo strumento validato più utilizzato per rilevare e misurare la gravità dell'ansia. Sviluppata alla Columbia University, è riconosciuta dai clinici di tutto il mondo.

⏱ 3 min ❓ 7 domande ✓ 100% Free
▶ Inizia Test Gratuito
🔒 No registration · Instant results
🔬 Screening dell'Ansia (GAD-7)
▶ Inizia il Test Ora
Download sample PDF →
⚠️ Avviso: Questo strumento è solo informativo e non costituisce una diagnosi medica. Se l'ansia influisce sulla vita quotidiana, consultare un professionista della salute.
Claude AI
Interpretazione IA di Claude (Anthropic)
claude-sonnet-4-20250514
Your results are analyzed by Claude, Anthropic's AI model, which provides a personalized narrative explaining what your answers reveal about your profile, with practical recommendations and professional guidance.

📋 What to expect

Rispondi onestamente Non ci sono risposte giuste o sbagliate
Prenditi il tuo tempo Leggi attentamente ogni domanda prima di rispondere
Interpretazione IA L'IA Claude analizzerà e spiegherà i tuoi risultati
PDF Report Get a full PDF report of your results

What is Generalised Anxiety Disorder?

Generalised Anxiety Disorder (GAD) is characterised by excessive, persistent worry about various areas of daily life (work, health, family, finances), difficult to control and present on most days for at least 6 months. GAD affects approximately 6% of people at some point in their lives. It differs from ordinary stress by its pervasive nature, persistence, and accompanying physical symptoms (muscle tension, sleep disturbance, fatigue).

Common symptoms

GAD symptoms include: excessive and difficult-to-control worry, irritability, concentration difficulties, chronic fatigue, muscle tension, sleep disturbances, and a constant feeling of being on edge. Work-related anxiety, night-time rumination, and avoidance of stressful situations are also characteristic.

About the GAD-7

The GAD-7 is a validated anxiety screening and severity scale developed by Spitzer et al. (2006), published in Archives of Internal Medicine. It is widely used in primary care and clinical research. A score ≥ 10 is associated with moderate-to-severe GAD warranting clinical evaluation.